Imaging synaptic neurotransmission with in vivo binding competition techniques:: A critical review

被引:775
作者
Laruelle, M
机构
[1] Columbia Univ, New York State Psychiat Inst, Dept Psychiat, New York, NY 10032 USA
[2] Columbia Univ, Coll Phys & Surg, Dept Psychiat & Radiol, New York, NY USA
关键词
positron emission tomography; single-photon emission computed tomography dopamine; raclopride; IBZM; spiperone; internalization;
D O I
10.1097/00004647-200003000-00001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several groups have provided evidence that positron emission tomography (PET) and single-photon emission computed tomography (SPECT) neuroreceptor imaging techniques might be applied to measure acute fluctuations in dopamine (DA) synaptic concentration in the living human brain. Competition between DA and radioligands for binding to D-2 receptor is the principle underlying this approach. This new application of neuroreceptor imaging provides a dynamic measurement of neurotransmission that is likely to be informative to our understanding of neuropsychiatric conditions. This article reviews and discusses the body of data supporting the feasibility and potential of this imaging paradigm. Endogenous competition studies performed in rodents, nonhuman primates, and humans are first summarized. After this overview, the validity of the model underlying the interpretation of these imaging data is critically assessed. The current reference model is defined as the occupancy model, since changes in radiotracer binding potential (BP) are assumed to be directly caused by changes in occupancy of D-2 receptors by DA. Experimental data supporting this model are presented. The evidence that manipulation of DA synaptic levels induces change in the BP of several D2 radiotracers (catecholamines and benzamides) is unequivocal. The fact that these changes in BP are mediated by changes in DA synaptic concentration is well documented. The relationship between the magnitude of BP changes measured with PET or SPECT and the magnitude of changes in DA concentration measured by microdialysis supports the use of these noninvasive techniques to measure changes in neurotransmission. On the other hand, several observations remain unexplained. First, the amphetamine-induced changes in the BP of D-2 receptor antagonists [I-123]IBZM and [C-11]raclopride last longer than amphetamine-induced changes in DA extracellular concentration. Second, nonbenzamide D-2 receptor antagonists, such as spiperone and pimozide, are not affected by changes in DA release, or are affected in a direction opposite to that predicted by the occupancy model. Similar observations are reported with D-1 radiotracers. These results suggest that the changes in BP following changes in DA concentration might not be fully accounted by a simple occupancy model. Specifically, the data are reviewed supporting that agonist-mediated receptor internalization might play an important role in characterizing receptor-ligand interactions. Finally, it is proposed that a better understanding of the mechanism underlying the effects observed with benzamides is essential to develop this imaging technique to other receptor systems.
引用
收藏
页码:423 / 451
页数:29
相关论文
共 224 条
  • [41] STRIATAL BINDING OF THE PET LIGAND C-11 RACLOPRIDE IS ALTERED BY DRUGS THAT MODIFY SYNAPTIC DOPAMINE LEVELS
    DEWEY, SL
    SMITH, GS
    LOGAN, J
    BRODIE, JD
    FOWLER, JS
    WOLF, AP
    [J]. SYNAPSE, 1993, 13 (04) : 350 - 356
  • [42] Ding YS, 1998, J NUCL MED, V39, p12P
  • [43] THE EFFECT OF RESERPINE TREATMENT IN-VIVO UPON L-DOPA AND AMPHETAMINE EVOKED DOPAMINE AND DOPAC EFFLUX IN-VITRO FROM THE CORPUS STRIATUM OF MALE-RATS
    DLUZEN, DE
    LIU, B
    [J]. JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1994, 95 (03) : 209 - 222
  • [44] PH-DEPENDENCE OF LIGAND-BINDING TO D-2 DOPAMINE-RECEPTORS
    DSOUZA, UM
    STRANGE, PG
    [J]. BIOCHEMISTRY, 1995, 34 (41) : 13635 - 13641
  • [45] Dumartin B, 1998, J NEUROSCI, V18, P1650
  • [46] PREPARATION OF C-11-LABELLED RACLOPRIDE, A NEW POTENT DOPAMINE RECEPTOR ANTAGONIST - PRELIMINARY PET STUDIES OF CEREBRAL DOPAMINE-RECEPTORS IN THE MONKEY
    EHRIN, E
    FARDE, L
    DEPAULIS, T
    ERIKSSON, L
    GREITZ, T
    JOHNSTROM, P
    LITTON, JE
    NILSSON, JLG
    SEDVALL, G
    STONEELANDER, S
    OGREN, SO
    [J]. INTERNATIONAL JOURNAL OF APPLIED RADIATION AND ISOTOPES, 1985, 36 (04): : 269 - &
  • [47] Kinetic modeling of [C-11]raclopride: Combined PET-microdialysis studies
    Endres, CJ
    Kolachana, BS
    Saunders, RC
    Su, T
    Weinberger, D
    Breier, A
    Eckelman, WC
    Carson, RE
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1997, 17 (09) : 932 - 942
  • [48] Assessment of dynamic neurotransmitter changes with bolus or infusion delivery of neuroreceptor ligands
    Endres, CJ
    Carson, RE
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1998, 18 (11) : 1196 - 1210
  • [49] PHARMACOLOGY OF BINDING OF H-3 SCH-23390 TO D-1 DOPAMINERGIC RECEPTOR-SITES IN RAT STRIATAL TISSUE
    FAEDDA, G
    KULA, NS
    BALDESSARINI, RJ
    [J]. BIOCHEMICAL PHARMACOLOGY, 1989, 38 (03) : 473 - 480
  • [50] FARDE L, 1990, ARCH GEN PSYCHIAT, V47, P213